查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1433294

全球自体伤口贴片市场 2023-2030

Global Autologous Wound Patches Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 210 Pages | 商品交期: 2-3个工作天内

价格

预计全球自体伤口贴片市场在预测期内（2023-2030）将以 9.2% 的CAGR成长。自体伤口贴片为患者提供了新的治疗选择，因为它们有助于加速伤口癒合并降低併发症的风险。全身皮肤损伤持续扰乱数百万患者的日常生活，导致住院时间延长、感染和死亡。伤口癒合设备的进步改善了临床实践，但主要集中在治疗宏观癒合而不是潜在的微观病理生理学。使用一系列伤口癒合产品的最佳治疗策略缺乏共识，这推动了新疗法的设计。

细分市场前景

全球自体伤口贴片市场按类型、应用程式和最终用户进行细分。依类型，市场分为富血小板血浆和富血小板纤维蛋白。根据应用，市场分为急性伤口和慢性伤口。根据最终用户，市场分为医院、诊所和门诊手术中心。在该类型中，富含血小板的纤维蛋白细分市场预计将占据相当大的市场份额，因为它的旋转速度较低，这使得一些白血球和干细胞能够保持完整因此，富含血小板的纤维蛋白斑块中存在更多的癒合因子，有助于慢性伤口更快的癒合。

预计慢性伤口细分市场将在全球自体伤口贴片市场中占据相当大的份额

其中，慢性伤口细分市场预计将在全球自体伤口贴片市场中占据相当大的份额。这种节段性生长归因于多种因素，例如慢性伤口、先进绷带针对失调的发炎阶段、替换皮肤组织并防止感染。在糖尿病伤口中，最近的注意力集中在透过诱导急性发炎来启动癒合过程。肥大细胞稳定剂的预防性递送和神经肽 P 物质的释放都会在糖尿病小鼠受伤后诱导强烈的炎症，改善伤口上皮再形成，并加速伤口癒合。根据世界卫生组织统计，全球约有 4.22 亿人患有糖尿病，其中大多数生活在低收入和中等收入国家，每年有 150 万人死亡直接归因于糖尿病。在过去的几十年里，糖尿病的病例数和盛行率都在稳定增加。

区域展望

全球自体伤口贴片市场根据地理位置进一步细分，包括北美（美国和加拿大）、欧洲（英国、义大利、西班牙、德国、法国和欧洲其他地区）、亚太地区（印度、中国、日本、韩国和亚洲其他地区）以及世界其他地区（中东和非洲以及拉丁美洲）。其中，亚太地区预计将在全球市场中占据显着份额，因为该地区道路和创伤事故数量不断增加，导致复杂伤口患者数量增加。自体伤口贴片特别适合治疗此类伤口，因为它们可以帮助促进组织再生并轻鬆修復损伤。

欧洲地区全球自体伤口贴片市场预计将以显着的CAGR成长

在所有地区中，欧洲地区预计在预测期内将以相当大的CAGR成长。区域成长归功于该地区的医疗进步和创新。人们越来越关注开发新型和创新的自体伤口贴片，这些贴片具有改进的特性，例如更快的癒合时间、减少的疼痛和不适以及易于使用。例如，2023 年7 月，RedDress（由患者自己的全血创建的个人化自体伤口护理解决方案）宣布，其ActiGraft PRO 产品现已在美国各地上市，并且有资格透过NCD 270.3 从Medicare 和Medicare Advantage 获得全国范围内的报销以及 G-0465 和 G-0460 代码。它使医疗保健提供者能够从患者自己的血液中「即时」产生体外血块。一旦使用，血块就会充当保护层并支持身体的自然伤口癒合反应。它可用于各种难以治疗的慢性伤口，包括糖尿病足溃疡、压力性损伤、静脉性溃疡、外伤伤口和手术后伤口。

市场参与者展望

服务自体伤口贴片市场的主要公司包括 Reapplix、PRP Concepts、RedDress、Nuo Therapeutics 等。市场参与者透过各种策略（包括併购、合作、合作、融资和新产品发布），为市场成长做出了巨大贡献，以保持市场竞争力。例如，2023 年8 月，ActiGraft PRO 系统（一种由患者自己的全血创建的个人化自体伤口护理解决方案）的开发商RedDress 宣布，其ActiGraft PRO 产品现已透过美国最大的提供者驱动的医疗保健Vizient 提供绩效改善公司。此外，它还宣布与 Asker Healthcare Group 旗下的 OneMed 建立策略合作伙伴关係，在芬兰各地商业化和分销 ActiGraft 系统。

报告涵盖：

  • 2022年市场价​​值资料分析及2030年预测。
  • 每个细分市场的年化市场收入（百万美元）。
  • 主要地理区域的国家分析。
  • 在全球自体伤口贴片市场中营运的主要公司。根据现有资料，报告中还提供了与新产品发布相关的资讯以及相关新闻。
  • 透过确定未来强劲成长的关键细分市场来分析业务策略。
  • 市场进入和市场扩张策略分析。
  • 透过识别市场中「谁的立场」来制定竞争策略。

目录

第 1 章：报告摘要

  • 目前行业分析及成长潜力展望
  • 研究方法和工具
  • 市场区隔
    • 按细分
    • 按地区

第 2 章：市场概述与见解

  • 报告范围
  • 分析师见解和当前市场趋势
    • 主要发现
    • 建议
    • 结论

第 3 章：竞争格局

  • 主要公司分析
  • PRP Concepts
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • Reapplix A/S
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • RedDress
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • 关键策略分析

第 4 章：市场细分

  • 按类型分類的全球自体伤口贴片市场
    • 富血小板血浆
    • 富含血小板纤维蛋白
  • 全球自体伤口贴片市场（按应用）
    • 急性伤口
    • 慢性伤口
  • 按最终用户分類的全球自体伤口贴片市场
    • 医院
    • 诊所
    • 门诊手术中心

第 5 章：区域分析

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 义大利
    • 西班牙
    • 法国
    • 欧洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 世界其他地区

第 6 章：公司简介

  • 3M Healthcare
  • ACell Inc.
  • Advanced BioHealing
  • AlloSource
  • Avita Medical
  • Coloplast
  • ConvaTec
  • Integra LifeSciences Corp
  • MiMedx Group, Inc.
  • Molnlycke Health Care AB
  • Nuo Therapeutics
  • NuVasive
  • Organogenesis Holdings Inc.
  • Osiris Therapeutics, Inc.
  • Smith & Nephew plc
  • TissueTech, Inc.
Product Code: OMR2027930

Global Autologous Wound Patches Market Size, Share & Trends Analysis Report by Type (Platelet Rich Plasma and Platelet Rich Fibrin), by Application (Acute wound and chronic wound), and by End-User (Hospitals, Clinics, and Ambulatory Surgical Center), Forecast Period (2023-2030)

The global autologous wound patches market is anticipated to grow at a CAGR of 9.2% during the forecast period (2023-2030). Autologous wound patches offer new treatment option for patients, as they can help to accelerate wound healing and reduce the risk of complications. Skin injuries across the body continue to disrupt everyday life for millions of patients and result in prolonged hospital stays, infection, and death. Advances in wound healing devices have improved clinical practice but have mainly focused on treating macroscale healing versus underlying microscale pathophysiology. Consensus is lacking on optimal treatment strategies using a spectrum of wound healing products, which has motivated the design of new therapies.

Segmental Outlook

The global autologous wound patches market is segmented on the type, application, and end-user. Based on the type, the market is sub-segmented into platelet rich plasma and platelet rich fibrin. Based on application, the market is sub-segmented into acute wound and chronic wound. Based on the end-user, the market is sub-segmented into a hospitals, clinics, and ambulatory surgical center. Among the type, the Platelet rich fibrin sub-segment is anticipated to hold a considerable share of the market, owing to factor which includes, it spun at a lower speed, which allows some of the white blood cells & stem cells to remain intact with the platelet layer, as a result, more healing factors are present in platelet rich fibrin patches, which supports faster healing of chronic wounds.

The chronic wound Sub-Segment is Anticipated to Hold a Considerable Share of the Global Autologous wound patches Market

Among the application, the chronic wound sub-segment is expected to hold a considerable share of the global Autologous wound patches market. This segmental growth is attributed to several factor such as, chronic wounds, advanced bandages target the dysregulated inflammatory phase, replace skin tissue, and protect against infection. In diabetic wounds, recent attention focused on jump-starting the healing process by inducing acute inflammation. The preventive delivery of a mast cell stabilizer and the release of the neuropeptide substance P both induced strong inflammation after wounding, improved wound re-epithelialization, and accelerated wound healing in diabetic mice. According to World health organization, about 422 million people worldwide have diabetes, the majority living in low-and middle-income countries, and 1.5 million deaths are directly attributed to diabetes each year. Both the number of cases and the prevalence of diabetes have been steadily increasing over the past few decades.

Regional Outlook

The global autologous wound patches market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia pacific is anticipated to hold a prominent share of the market across the globe, owing to Increasing number of road and traumatic accidents in the region, leading to a rise in the number of patients with complex wounds. Autologous wound patches are particularly suitable for treating these types of wounds, as they can help to promote tissue regeneration and repair the damage easily.

The European Region is Expected to Grow at a Significant CAGR in the Global Autologous wound patches Market

Among all regions, the European regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to medical advancements and innovation in the region. There is a growing focus on developing new and innovative autologous wound patches with improved properties such as faster healing times, reduced pain and discomfort, and ease of use. For instance, In July 2023, RedDress, a personalized and autologous wound care solution created from patients own whole blood, announced that its ActiGraft PRO product is now commercially available throughout the US and is eligible for reimbursement nationally from Medicare and Medicare Advantage via NCD 270.3 and G-0465 & G-0460 codes. it enables health care providers to produce, 'in real time' in vitro blood clots from a patient's own blood. Once applied, the blood clot serves as a protective covering and supports the body's natural wound healing response. it can be used for a wide variety of hard-to-treat chronic wounds, including diabetic foot ulcers, pressure injuries, venous ulcers, traumatic wounds and post-surgical wounds.

Market Players Outlook

The major companies serving the autologous wound patches market include Reapplix, PRP Concepts, RedDress, Nuo Therapeutics, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, In August 2023, RedDress, developers of the ActiGraft PRO system, a personalized and autologous wound care solution created from patients' own whole blood, announced that its ActiGraft PRO product is now available through Vizient, the nation's largest provider-driven healthcare performance improvement company. Additionally, it announced also established a strategic partnership with OneMed, part of the Asker Healthcare Group, to commercialize and distribute the ActiGraft system throughout Finland.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global autologous wound patches market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. PRP Concepts
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Reapplix A/S
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. RedDress
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Autologous wound patches Market by Type
    • 4.1.1. Platelet Rich Plasma
    • 4.1.2. Platelet Rich Fibrin
  • 4.2. Global Autologous wound patches Market by Application
    • 4.2.1. Acute wound
    • 4.2.2. Chronic wound
  • 4.3. Global Autologous wound patches Market by End-User
    • 4.3.1. Hospitals
    • 4.3.2. Clinics
    • 4.3.3. Ambulatory Surgical Center

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. 3M Healthcare
  • 6.2. ACell Inc.
  • 6.3. Advanced BioHealing
  • 6.4. AlloSource
  • 6.5. Avita Medical
  • 6.6. Coloplast
  • 6.7. ConvaTec
  • 6.8. Integra LifeSciences Corp
  • 6.9. MiMedx Group, Inc.
  • 6.10. Molnlycke Health Care AB
  • 6.11. Nuo Therapeutics
  • 6.12. NuVasive
  • 6.13. Organogenesis Holdings Inc.
  • 6.14. Osiris Therapeutics, Inc.
  • 6.15. Smith & Nephew plc
  • 6.16. TissueTech, Inc.

LIST OF TABLES

  • 1. GLOBAL AUTOLOGOUS WOUND PATCHES MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 2. GLOBAL PLATELET RICH PLASMA IN AUTOLOGOUS WOUND PATCHES MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 3. GLOBAL PLATELET RICH FIBRIN IN AUTOLOGOUS WOUND PATCHES MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 4. GLOBAL AUTOLOGOUS WOUND PATCHES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 5. GLOBAL AUTOLOGOUS WOUND PATCHES IN ACUTE WOUND MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL AUTOLOGOUS WOUND PATCHES IN CHRONIC WOUND MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL AUTOLOGOUS WOUND PATCHES MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 8. GLOBAL AUTOLOGOUS WOUND PATCHES FOR HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL AUTOLOGOUS WOUND PATCHES FOR CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 10. GLOBAL AUTOLOGOUS WOUND PATCHES FOR AMBULATORY SURGICAL CENTER MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 11. GLOBAL AUTOLOGOUS WOUND PATCHES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 12. NORTH AMERICAN AUTOLOGOUS WOUND PATCHES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 13. NORTH AMERICAN AUTOLOGOUS WOUND PATCHES MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 14. NORTH AMERICAN AUTOLOGOUS WOUND PATCHES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 15. NORTH AMERICAN AUTOLOGOUS WOUND PATCHES MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 16. EUROPEAN AUTOLOGOUS WOUND PATCHES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 17. EUROPEAN AUTOLOGOUS WOUND PATCHES MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 18. EUROPEAN AUTOLOGOUS WOUND PATCHES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 19. EUROPEAN AUTOLOGOUS WOUND PATCHES MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 20. ASIA- PACIFIC AUTOLOGOUS WOUND PATCHES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 21. ASIA- PACIFIC AUTOLOGOUS WOUND PATCHES MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 22. ASIA- PACIFIC AUTOLOGOUS WOUND PATCHES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 23. ASIA- PACIFIC AUTOLOGOUS WOUND PATCHES MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 24. REST OF THE WORLD AUTOLOGOUS WOUND PATCHES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 25. REST OF THE WORLD AUTOLOGOUS WOUND PATCHES MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 26. REST OF THE WORLD AUTOLOGOUS WOUND PATCHES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 27. REST OF THE WORLD AUTOLOGOUS WOUND PATCHES MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL AUTOLOGOUS WOUND PATCHES MARKET SHARE BY TYPE, 2022 VS 2030 (%)
  • 2. GLOBAL PLATELET RICH PLASMA IN AUTOLOGOUS WOUND PATCHES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL PLATELET RICH FIBRIN IN AUTOLOGOUS WOUND PATCHES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL AUTOLOGOUS WOUND PATCHES MARKET SHARE BY APPLICATION, 2022 VS 2030 (%)
  • 5. GLOBAL ACUTE WOUND AUTOLOGOUS WOUND PATCHES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL CHRONIC WOUND AUTOLOGOUS WOUND PATCHES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL AUTOLOGOUS WOUND PATCHES MARKET SHARE BY END-USER, 2022 VS 2030 (%)
  • 8. GLOBAL AUTOLOGOUS WOUND PATCHES FOR HOSPITALS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL AUTOLOGOUS WOUND PATCHES FOR CLINICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 10. GLOBAL AUTOLOGOUS WOUND PATCHES FOR AMBULATORY SURGICAL CENTER MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 11. GLOBAL AUTOLOGOUS WOUND PATCHES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 12. US AUTOLOGOUS WOUND PATCHES MARKET SIZE, 2022-2030 ($ MILLION)
  • 13. CANADA AUTOLOGOUS WOUND PATCHES MARKET SIZE, 2022-2030 ($ MILLION)
  • 14. UK AUTOLOGOUS WOUND PATCHES MARKET SIZE, 2022-2030 ($ MILLION)
  • 15. FRANCE AUTOLOGOUS WOUND PATCHES MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. GERMANY AUTOLOGOUS WOUND PATCHES MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. ITALY AUTOLOGOUS WOUND PATCHES MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. SPAIN AUTOLOGOUS WOUND PATCHES MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. REST OF EUROPE AUTOLOGOUS WOUND PATCHES MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. INDIA AUTOLOGOUS WOUND PATCHES MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. CHINA AUTOLOGOUS WOUND PATCHES MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. JAPAN AUTOLOGOUS WOUND PATCHES MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. SOUTH KOREA AUTOLOGOUS WOUND PATCHES MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. REST OF ASIA-PACIFIC AUTOLOGOUS WOUND PATCHES MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. REST OF THE WORLD AUTOLOGOUS WOUND PATCHES MARKET SIZE, 2022-2030 ($ MILLION)